On December 31, 2015 Dyadic announced the closing of the previously announced sale of substantially all of the assets of its Industrial Technology business to DuPont Industrial Biosciences, including Dyadic's C1 platform, a fungal expression technology for producing enzymes. This acquisition includes Dyadic's research and development lab located in Wageningen, The Netherlands.

Among others the division develops strains of the fungus Myceliophthora thermophila - or C1 - to rapidly discover and express genes and to manufacture the enzymes encoded by those genes, using C1 as the host organism. Read more

Learn more about Industrial Biotechnology solutions from DuPont

disclaimer - Dyadic International